Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Efficacy of Hippotherapy Program on Disease Symptoms, Quality of Life, Anxiety and Loneliness Levels in Patients With Schizophrenia: A Randomized Controlled Trial

NCT06303596 is registered in ClinicalTrials.gov with Erzurum Technical University as lead sponsor.

NCT NCT06303596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06303596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Efficacy of Hippotherapy Program on Disease Symptoms, Quality of Life, Anxiety and Loneliness Levels in Patients With Schizophrenia: A Randomized Controlled Trial
Lead sponsor
Erzurum Technical University
Phase
Not applicable
Overall status
Unknown status
Start date
March 20, 2024
Completion date
October 1, 2024
Enrollment
88 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

equine-assisted therapy, schizophrenia